Cannabigerol (CBG) is a type of cannabinoid found in the cannabis plant. It is often referred to as the "mother of all cannabinoids" because it is the parent molecule from which other cannabinoids are synthesized. CBG is normally a minor constituent of cannabis, and during plant growth, most of the cannabigerol is converted into other cannabinoids, primarily tetrahydrocannabinol (THC) or cannabidiol (CBD), leaving about 1% cannabigerol in the plant. However, some strains produce larger amounts of cannabigerol and cannabigerolic acid, while having low quantities of other cannabinoids, like THC and CBD.
CBG has shown promise in treating certain neurodegenerative and inflammatory conditions. Some studies suggest that CBG may provide therapeutic potential in treating inflammatory bowel disease (IBD) . CBG may also help people with multiple sclerosis. However, more research is needed to fully understand the therapeutic benefits of CBG.
In summary, CBG is a cannabinoid found in the cannabis plant that is the parent molecule from which other cannabinoids are synthesized. It has shown promise in treating certain neurodegenerative and inflammatory conditions, but more research is needed to fully understand its therapeutic benefits.
